Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model

Journal of NeuroVirology

Volumn 20, Issue 1, 2014, Pages 9-17

  Koneru, Rajeth ^a,b   Olive, M Foster ^c   Tyor, William R ^a,b  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Combined antiretroviral therapy; HIV encephalitis; HIV associated neurocognitive disorders; Neuropathology

Indexed keywords

ATAZANAVIR; EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; TENOFOVIR;

ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; ASTROCYTOSIS; BRAIN DAMAGE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; GLIOSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS ENCEPHALITIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MONONUCLEAR PHAGOCYTE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; VIRUS ENCEPHALITIS; VIRUS LOAD;

AIDS DEMENTIA COMPLEX; ANIMALS; ANTI-RETROVIRAL AGENTS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, SCID; VIRAL LOAD;

EID: 84896711212     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0223-5     Document Type: Article

References (33)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799
2. Avgeropoulos N, Kelley B, Middaugh L, Arrigo S, Persidsky Y, Gendelman HE, Tyor WR (1998) SCID mice with HIV encephalitis develop behavioral abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 18:13-20
3. Chugh P, Fan S, Planelles V, Maggirwar SB, Dewhurst S, Kim B (2007) Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line. J Mol Biol 366:67-81
4. Cook JE, Dasgupta S, Middaugh LD, Terry EC, Gorry PR, Wesselingh SL, Tyor WR (2005) Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Ann Neurol 57:795-803
5. Cook-Easterwood J, Middaugh LD, Griffin WC 3rd, Khan I, Tyor WR (2007) Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis. Exp Neurol 205:506-512
6. Cysique LA, Maruff P, Brew BJ (2004) Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 61:1699-1704
7. Ene L, Duiculescu D, Ruta SM (2011) How much do antiretroviral drugs penetrate into the central nervous system? J Med Life 4:432-439
8. Fritz-French C, Tyor W (2012) Interferon-alpha (IFNalpha) neurotoxicity. Cytokine Growth Factor Rev 23:7-14
9. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38:755-762
10. Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I (2009) White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol 15:187-195
11. Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69-81
12. Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen L, Masliah E (2004) Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. J Neuropathol Exp Neurol 63:1038-1047
13. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008a) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65-70
14. Letendre S, McCutchan JA, Ellis RJ (2008b) Highlights of the. In: 15th Conference on retroviruses and opportunistic infections. Neurologic complications of HIV disease and their treatment. Top HIV Med 16., pp 15-22
15. Lipton SA, Gendelman HE (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332:934-940
16. Loregian A, Pagni S, Ballarin E, Sinigalia E, Parisi SG, Palu G (2006) Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection. J Pharm Biomed Anal 42:500-505
17. Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, McArthur JC, Robertson K (2009) Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23:1359-1366
18. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9:205-221
19. Mocchetti I, Bachis A, Avdoshina V (2012) Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport. Neurotox Res 21:79-89
20. Notari S, Bocedi A, Ippolito G, Narciso P, Pucillo LP, Tossini G, Donnorso RP, Gasparrini F, Ascenzi P (2006) Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 831:258-266
21. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853-860
22. Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd (2009) Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 23:1893-1901
23. Portegies P, Enting RH, de Gans J, Algra PR, Derix MM, Lange JM, Goudsmit J (1993) Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS 7:669-675
24. Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ (2010) Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology 74:1260-1266
25. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8:136-142
26. Saksena NK, Potter SJ (2003) Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy. AIDS Rev 5:3-18
27. Sas AR, Bimonte-Nelson H, Smothers CT, Woodward J, Tyor WR (2009) Interferon-alpha causes neuronal dysfunction in encephalitis. J Neurosci 29:3948-3955
28. Sentenac S, Fernandez C, Thuillier A, Lechat P, Aymard G (2003) Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 793:317-324
29. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31:349-360
30. Tyor WR, Power C, Gendelman HE, Markham RB (1993) A model of human immunodeficiency virus encephalitis in SCID mice. Proc Natl Acad Sci U S A 90:8658-8662
31. Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N (2004a) Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63:822-827
32. Valcour VG, Shikuma CM, Watters MR, Sacktor NC (2004b) Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS 18(Suppl 1):S79-S86
33. Varatharajan L, Thomas SA (2009) The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res 82:A99-A109